Association between serum albumin and 60-day mortality in Chinese Hakka patients with non-APL acute myeloid leukemia: a retrospective cohort study

Albumin vs 60-day mortality in non-APL acute myeloid leukemia — A 6% decrease in 60-day mortality rate per a 1 g/L increase in ALB (HR=0.94; 0.89/0.99; P=0.015) — 60-day mortality rates in Q2 (HR=0.50; 0.30/0.86; P=.012) and Q3 (HR=0.47; 0.25/0.90; P=.022)

New article: Association between serum albumin and 60-day mortality in Chinese Hakka patients with non-APL acute myeloid leukemia: a retrospective cohort study https://t.co/VXZAhuGK87 #AML #leusm #hematology https://t.co/sukcEj3lPo